In the News

Online reporting of blood glucose may lower HbA1c in diabetes patients on oral meds

The results suggest that highly adherent diabetes patients who self-monitor their blood glucose could benefit from reporting their results, study authors concluded.

Adding DPP-4s to sulfonylureas may increase hypoglycemia risk

The review of 10 randomized controlled trials found 1 excess case of hypoglycemia for every 17 patients in the first 6 months of combined treatment.

1-hour glucose value may predict mortality risk

A 1-hour glucose value above 155 mg/dL predicted mortality even when the 2-hour glucose value was below 140 mg/dL, according to the 33-year study.

MKSAP quiz: first-line medication for type 2 diabetes

This month's quiz asks readers to choose a medication for a patient who has been managing her type 2 diabetes with lifestyle modifications.

Heart failure hospitalizations similar with DPP-4 inhibitors and other drug options

The retrospective cohort study used data on almost 80,000 new saxagliptin users and almost 300,000 new sitagliptin users, gathered through the FDA's Mini-Sentinel program from 2006 to 2013.

Score may help predict which patients are likely to achieve type 2 diabetes cure after bariatric surgery

DiaRem, a weighted score ranging from 0 to 22 points, is based on age, insulin dependence, diabetes medication use, and HbA1c level.

Spotlight on metformin

In the past month, a new meta-analysis compared metformin to other diabetes drugs, and the FDA expanded metformin's indications in patients with reduced kidney function.